Vizgen

Vizgen

Biotechnology Research

Cambridge, Massachusetts 16,200 followers

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis

About us

Ultivue recently merged with Vizgen to lead the next frontier of innovation in spatial biology and multi-omics. Through its pioneering MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics and its high-fidelity InSituPlex® assays and AI-driven STARVUE™ spatial image analysis technology, Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases. Vizgen’s technology delivers high-confidence, quantitative data with exceptional accuracy, robustness, sensitivity and deep insights that power foundational and clinical research. Named the #1 private spatial biology company of 2024 by Genetic Engineering & Biotechnology News, Vizgen is headquartered in Cambridge, Massachusetts.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held
Founded
2019
Specialties
translational research, single cell genomics, multi-omics, transcriptomics, spatial gene expression , single cell gene expression, in situ single-cell omics, cell atlases, Human Cell Atlas, spatial genomics research, RNA Imaging in situ, spatially-resolved RNA profiling, high throughput, high resolution, high multiplexing, high accuracy, drug development, immunology, neuroscience, and cancer research

Locations

Employees at Vizgen

Updates

Similar pages

Browse jobs

Funding

Vizgen 4 total rounds

Last Round

Series D
See more info on crunchbase